Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3065

Actual shortage: 231 (8%)
Anticipated shortage: 16 (1%)
Avoided shortage: 9 (0%)
Resolved: 2809 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

30 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-05-19 2023-07-21 192800
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-05-19 2023-06-23 192818
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-07-27 2024-03-15 200177
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-08-23 2023-11-06 202824
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-09-28 2024-03-15 205480
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-11-06 2024-03-15 209286
APO-TRAVOPROST-TIMOP PQ 0.5% 0.004% SOLUTION Resolved 2020-02-05 2020-03-06 105364
APO-TRAVOPROST-TIMOP PQ 0.5% 0.004% SOLUTION Resolved 2023-04-27 2023-07-13 190871
APO-TRAVOPROST-TIMOP PQ 0.5% 0.004% SOLUTION Resolved 2023-08-04 2023-08-12 201162
APO-BRIMONIDINE-TIMOP 0.5% 0.2% SOLUTION Resolved 2024-05-03 2024-05-10 227028
APO-TIMOP GEL 0.5% SOLUTION Resolved 2017-03-11 2019-02-05 510
APO-LEVOBUNOLOL OPHTHALMIC SOLUTION USP 0.5% 0.5% LIQUID Actual shortage 2017-08-13 2017-10-05 19093
APO-MOXIFLOXACIN 0.5% SOLUTION Resolved 2018-01-18 2018-03-13 36435
APO-MOXIFLOXACIN 0.5% SOLUTION Resolved 2018-05-02 2018-07-12 47966
APO-TIMOP 0.5% SOLUTION Resolved 2018-05-08 2019-02-05 48866
APO-TIMOP 0.5% SOLUTION Resolved 2018-05-15 2018-11-02 49509
APO-TIMOP 0.5% SOLUTION Resolved 2019-09-04 2020-07-29 92992
APO-MOXIFLOXACIN 0.5% SOLUTION Resolved 2019-10-30 2020-03-09 97474
APO-TIMOP 0.5% SOLUTION Resolved 2021-01-04 2021-12-13 130810
APO-TIMOP 0.5% SOLUTION Actual shortage 2024-01-05 2024-05-03 215215

Showing 121 to 140 of 3065

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-TERAZOSIN 2MG TABLET Discontinued 2017-03-31 2018-02-05 4974
APO-SALVENT TABLETS - 2MG 2MG TABLET Discontinued 2018-02-23 2018-12-28 40854
APO-TOLTERODINE 2MG TABLET Discontinued 2018-09-08 2018-11-09 60825
APO-TOLTERODINE 2MG TABLET Discontinued 2018-09-08 2019-06-12 60828
APO-RISPERIDONE 3.0MG TABLET Discontinued 2018-09-08 2019-06-12 60750
APO-CARVEDILOL 3.125MG TABLET To be discontinued 2024-01-26 2024-01-26 217496
APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE 300MG 150MG 300MG TABLET Discontinued 2022-12-12 2022-12-12 177953
APO-DILTIAZ TZ 300MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1075
APO-NIZATIDINE 300MG CAPSULE Discontinued 2017-03-13 2017-03-13 1135
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-CLINDAMYCIN 300MG CAPSULE Discontinued 2018-09-07 2019-07-13 60399
APO-IBUPROFEN 300MG TABLET Discontinued 2018-09-07 2018-09-15 60527
APO-IRBESARTAN 300MG TABLET Discontinued 2018-09-07 2018-09-15 60539
APO-LAMIVUDINE 300MG TABLET Discontinued 2018-09-07 2019-07-13 60560
APO-LITHIUM CARBONATE 300MG CAPSULE Discontinued 2018-09-07 2018-09-15 60588
APO-QUETIAPINE 300MG TABLET Discontinued 2018-09-08 2018-12-28 60708
APO-QUININE 300MG CAPSULE Discontinued 2018-09-08 2021-05-10 60714
APO-RANITIDINE TABLET 300MG 300MG TABLET Discontinued 2018-09-08 2018-09-15 60729
APO-RANITIDINE TABLET 300MG 300MG TABLET To be discontinued 2018-09-08 2018-09-08 60732
APO-IBUPROFEN 300MG TABLET Discontinued 2019-01-02 2019-01-02 70793

Showing 221 to 240 of 356